Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 146 |
| Receivables | 10 |
| TOTAL | $156 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $156 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 70 |
| Other current liabilities | 7 |
| TOTAL | $81 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $81 |
| Shareholders' Equity | |
| Common Shares | 20 |
| Retained earnings | -229 |
| Other shareholders' equity | 4 |
| TOTAL | $75 |
| Total Liabilities And Equity | $156 |